Skip to content
CompletedN/A

Sustained Ketamine Effectiveness for Suicidal Ideation

NCT06806475 · SKESI · University Hospital, Montpellier

Closed to entry
Status
Not accepting participants
Not applicable
Phase
128
Target enrolment
1
Study sites
Outside the US

What it is testing

Summary

As part of the usual clinical activity of the Emergency and Post-Emergency Psychiatric Department, IV ketamine is used to treat suicidal crises in depressed patients hospitalized as an add-on to the treatment of depression. This infusion can be repeated. Patients are systematically reassessed twice in the month following the last infusion, to ensure that the suicidal crisis is progressing. Psychometric assessments are part of routine care, to ensure systematic evaluation of psychopathology, intensity of depression and suicidality. Therefore existing data were re-used from the medical records of patients who had received ketamine infusions to assess the effect of ketamine on suicidal ideation and behaviour.

Summary as written by the trial’s own sponsor and published on ClinicalTrials.gov API v2. It is the sponsor’s description, reproduced unedited, not an assessment by this site.

What counts as success

Primary outcome measures

  • suicidal ideation at 7 days after IV ketamine administration

    Measured over 7 days

A trial succeeds or fails on its primary outcome, declared in advance. Everything else it reports is secondary by definition.

Who can take part

Eligibility, as published

18 Years
Ages
All
Sex
Not accepted
Healthy volunteers
Inclusion Criteria: * Patients treated with IV ketamine in the Psychiatric Emergency and Post-Emergency Department (University Hospital, Montpellier) in context of suicidal crisis * over 18 y.o Exclusion Criteria: * Opposition to data use * Subject deprived of liberty (by judicial or administrative decision) * Subject protected by law (guardianship or curatorship) * Subject not affiliated to a social security system

Where

1 study site

FacilityCityRegionCountry
University Hospital, MontpellierMontpellierFrance

On the registry

Contact the trial directly

This site does not enrol anyone and is not involved in this trial. To ask about taking part, use the sponsor’s own contact details on the official registry record, which is also where the most current version of everything above lives.

Before you do, the preparation checklist lists what a site will ask you on a first call and what is worth asking them. It is free and collects nothing.

NCT06806475 on ClinicalTrials.gov →

Last updated in the registry 2025-03-30. Registry records change; this page reflects the data build of 2026-08-25.

Related

Where this trial sits